Next Article in Journal
A History of Heart Failure Is an Independent Risk Factor for Death in Patients Admitted with Coronavirus 19 Disease
Next Article in Special Issue
Superimposed Tissue Formation in Human Aortic Valve Disease: Differences between Regurgitant and Stenotic Valves
Previous Article in Journal
Early Aberrant Angiogenesis Due to Elastic Fiber Fragmentation in Aortic Valve Disease
Previous Article in Special Issue
Role of the Epicardium in the Development of the Atrioventricular Valves and Its Relevance to the Pathogenesis of Myxomatous Valve Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Pathology of the Aorta and Aorta as Homograft

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Cardiovascular Pathology, University of Padua Medical School, Via A. Gabelli, 61, 35121 Padua, Italy
*
Author to whom correspondence should be addressed.
J. Cardiovasc. Dev. Dis. 2021, 8(7), 76; https://0-doi-org.brum.beds.ac.uk/10.3390/jcdd8070076
Submission received: 6 May 2021 / Revised: 16 June 2021 / Accepted: 21 June 2021 / Published: 29 June 2021

Abstract

:
The aorta is not a rigid tube, it is an “organ” with lamellar units, consisting of elastic fibers, extracellular matrix and smooth muscle cells in between as parenchyma. Several diseases may occur in the natural history of the aorta, requiring replacement of both semilunar cusps and ascending aorta. They may be congenital defects, such as bicuspid aortic valve and isthmal coarctation with aortopathy; genetically determined, such as Marfan and William syndromes; degenerative diseases, such as atherosclerosis and medial necrosis with aortic dilatation, valve incompetence and dissecting aneurysm; inflammatory diseases such as Takayasu arteritis, syphilis, giant cell and IgM4 aortitis; neoplasms; and trauma. Aortic homografts from cadavers, including both the sinus portion with semilunar cusps and the tubular portion, are surgically employed to replace a native sick ascending aorta. However, the antigenicity of allograft cells, in the lamellar units and interstitial cells in the cusps, is maintained. Thus, an immune reaction may occur, limiting durability. After proper decellularization and 6 months’ implantation in sheep, endogenous cell repopulation was shown to occur in both the valve and aortic wall, including the endothelium, without evidence of inflammation and structural deterioration/calcification in the mid-term. The allograft was transformed into an autograft.

1. Introduction

Along with natural history, the aorta, the highway of our body, transforms from a smooth, pliable vessel in children into a rigid tube in the elderly (Figure 1) [1,2]. If normal or nearly normal, it may be donated at the time of death to serve as an arterial allograft for repair of both congenital and acquired diseases.
Here we will review gross and histologic features of normal and diseased aorta. Moreover, we will summarize the results of an experimental investigation, showing endogenous repopulation of decellularized aortic allografts implanted in juvenile sheep.

2. Normal Anatomy

The aorta is a smooth great vessel consisting of intima, media and adventitia. It is an elastic artery with variations in diameter during ventricular systole and diastole (“compliance”), thanks to elastic fibers of the tunica media (Figure 2a). They appear parallel with smooth muscle cells in between (Figure 2b). The number of elastic fibers varies from 56 in the ascending aorta and gradually decreases to 28 in the abdominal aorta. The intima is lined with endothelium and with time appears as a myointimal layer.
There are lamellar units in the media consisting of elastic fibers, smooth muscle cells and extracellular matrix (Figure 2c). The biological concept of the lamellar unit was put forward by Glagov in 1967 [3]. The aorta was considered as an organ with smooth muscle cells as parenchyma. The precise role of smooth muscle cells, whether synthetic, contractile or both, is still a matter under investigation [4,5]. The tunica adventitia consists of collagen fibers, nerves and vasa vasorum. The latter supplies the outer part of the tunica media in the thoracic aorta and not in the abdominal aorta, which is thinner because there are fewer lamellar units.

3. Pathology

The pathology may be congenital (structural defect present at birth), genetically determined with onset during childhood or even later, or acquired (inflammatory, degenerative, neoplastic, traumatic).

3.1. Congenital Malformations

Congenital malformations may affect the aortic valve, the ascending aorta and the aortic arch [6].
Bicuspid aortic valve (BAV) is a congenital defect with an incidence of 0.5–0.8% by echo in children (Figure 3) [7,8]. One of the two sinuses shows a raphe, most probably an aborted commissure during embryonic development.
In BAV type I the cusps appear antero-posterior (ventro-dorsal) with the raphe in the anterior sinus, due to embryonic fusion of anterior right and left cushions [9]. Both the coronary arteries originate from the anterior (ventral) sinus. In BAV type II the cusps appear side by side (latero-lateral) and the raphe the fusion of right and posterior cushions, with coronary arteries originating each from the opposite sinus. Under the raphe there is no interleaflet triangle (Figure 4). Rare cases of BAV without raphe do exist.
Natural history of BAV is characterized by progressive calcification of the cusps with aortic valve stenosis [10] and by aortopathy (Figure 5) with dilatation of the ascending aorta, valve incompetence and aortic dissection (Figure 6) [11,12,13].
BAV represents a well-known risk factor for infective endocarditis (Figure 7a,b). It is a cardiovascular risk factor in which antibiotic prophylaxis is recommended, for instance, in case of dental procedures.
Calcification of BAV is similar to senile calcific aortic stenosis and requires interventional repair with transcatheter aortic valve implantation (TAVI) or surgical repair-replacement. It occurs in adults and the elderly, usually ten years earlier than calcific senile.
Aortopathy develops with time in nearly 50% of BAV patients. Disruption of elastic fibers in the tunica media explains loss of wall elasticity as well as aneurysmal dilatation of both sinusal and tubular portions of the ascending aorta, with valve incompetence and even aortic dissection (Figure 6). Surgical replacement of the aorta, with repair of the valve, is indicated when the diameter of the aorta exceeds 5 cm [14]. Both increased aortic diameter and impaired elasticity of the stiffened wall can be assessed by 2D echo [15]. A hereditary Mendelian transmission with scanty penetrance has been advanced, but a definitive molecular genetic background, such as in Marfan syndrome, has not been proven so far.
The role of neurocrest in the development of BAV aortopathy has been conjectured since BAV is frequently (40–50%) associated with isthmic coarctation (Figure 8) [16].
Non-infective aneurysm of the sinuses of Valsalva represent a curious congenital malformation of the aortic root [17].

3.2. Genetically Determined Diseases of Thoracic Aorta

William’s syndrome is a dominant hereditary disease, due to molecular deletion of the elastic gene located in chromosome 7, accounting for increased wall thickness and stiffness of the ascending aorta [18,19]. The number of elastic fibers may be increased. Supravalvular aortic stenosis occurs in the shape of an hour-glass (Figure 9) in the diaphragm or hypoplastic ascending aorta. The aortic valve may be also involved with cusp thickening. Insulation of the coronary ostia may be observed because of the fusion of the cusps with sinus aortic wall.
In Marfan syndrome, the molecular defect consists in a mutation of the gene coding fibrillin 1, a protein connecting smooth muscle cells with elastic fibers of lamellar units in the tunica media [20]. The disease is hereditary dominant, frequently has de novo mutation, and involves joints, lens and the cardiovascular system. It is associated with aortopathy, similar to that of BAV, with disruption and loss of elastic fibers, medial necrosis, aortic dilatation and aortic and mitral valve incompetence. Loss of elastic fibers accounts for weakness and fragility of the aorta to such a degree that aortic dissection may occur, with risk of premature sudden death (Figure 10).
Recently, a new syndrome (Loeys-Dietz) has been reported, with an autosomal dominant pattern showing aortic lesions (Figure 11) similar to Marfan. It is due to mutations of genes coding transforming growth factor beta receptor (TGF BR) 1 or 2 [21]. The pathogenetic pathways in Marfan and Loeys-Dietz are similar [22]. Mutations of fibrillin 1 and TGF BR 1 and 2 all result in dysregulated TGB signaling. The main clinical characteristics are hypertelorism, cleft palate and bifid uvula, besides aortic tortuosity prone to dissection.
Ehlers-Danlos syndrome is a soft connective tissue disease, secondary to mutations in one of the genes coding collagen fiber or enzymes involved in collagens synthesis [23]. Six different forms of disease have been recognized. Pathological manifestations in the cardiovascular system are aortic aneurysm and dissection [24].
Turner syndrome is characterized by the absence of one X chromosome in a female. Aneurysmal dilatation of the aorta, BAV and isthmic coarctation are the phenotype, prone to aortic dissection [25].

3.3. Degenerative Diseases of the Aorta

Atherosclerosis is the “malignant” disease of the cardiovascular system, mostly related to aging and life style risk factors (smoke, lipid-rich foods…). Premature atherosclerosis is promoted by genetic hypercholesterolemia, the most frequent hereditary cardiovascular disorder (1:500). The disease starts in the intima with atherosclerotic plaque as an elementary lesion, which may complicate with rupture of the fibrous cap and thrombosis (atherothrombosis), a source of peripheral embolism and cause of stroke (Figure 12). The ulcer of an aortic plaque may penetrate into the media and create a local dissection with mural hematoma and false aneurysm at risk of external rupture (Figure 13). Moreover. the ulcerated plaque may be a site of microorganism settlement in the case of bacteremia, with development of mycotic aneurysm.
Atherosclerotic aneurysm is the complication of progressive thinning of the tunica media due to the release of proteases (elastase included) by monocytes, which play a pivotal role in the onset and progression of atherosclerosis [26]. Release of proteases in the intima may lead to thinning and rupture of the fibrous cap with thrombus deposition. On the outer side of the media, the release accounts for progressive thinning of the aortic wall with aneurysm formation (Figure 14). The occurrence of aortic atherosclerotic aneurysm is more frequent in the abdominal aorta, where the wall is thinner and the number of elastic lamellae is much lower.
Degenerative disease may primarily affect the tunica media with medionecrosis, elastic fiber fragmentation and an increase in extracellular ground substance in the lamellar units, even in the absence of a genetically determined disorder (Figure 15). It may account for aortic dilatation of the ascending aorta and aortic valve regurgitation, nowadays the most frequent cause of aortic incompetence. Both sinusal [27,28] and tubular portions appear dilated (Figure 16 and Figure 17). It was Currigan of Dublin who first recognized in 1832 the existence of a non-inflammatory cause of aortic incompetence, besides syphilis, rheumatism and infective endocarditis. It represents a fragile substrate favoring aortic dissection, which is featured by intimal tear and dissecting hematoma, triggered by mechanical stress [29] (Figure 18). Hypertensive attack is the main precipitating factor of dissecting aneurysm (Figure 19), which may originate either from the ascending or descending aorta. A more benign form does exist (so-called intramural hematoma), which lacks an intimal tear and is located in the thoracic aorta with the blood source from the vasa vasorum [30] (Figure 20). Hypertension is largely the more frequent risk factor (85%) of aorta dissection [31,32], followed by BAV and Marfan syndrome. Cases have been reported with familiarity (2–3%), distinct from Marfan [33,34,35].
Classic aortic dissection starts from an intimal tear and proceeds forward (antegrade dissection) in the outer tunica media, with risk of external rupture, hemopericardium and cardiac tamponade in the case of the ascending aorta or left hemothorax in the case of the descending aorta. The dissection transforms the aorta into two lumens (true and false) and may involve vital arteries, such as carotid and renal, with organ ischemic injury. Reentry may occur with distal intimal tears, leading a double barrel chronic dissection of the aorta (Figure 21) [36]. Retrograde dissection towards the aortic root may be responsible for commissural dehiscence with aortic valve incompetence and coronary stems dissection with myocardial infarction. (Figure 22). Hemorrhagic infiltration of the aorto-atrial space and atrial septum may account for av block due to atrio-nodal discontinuity.

3.4. Inflammatory Diseases of the Aorta

Inflammatory diseases of the aorta may be infectious or immune-mediated [37,38,39].
Syphilitic aortitis occurs late in the third stage of the disease [40]. The setting of Treponema pallidum in the tunica media triggers colliquative necrosis (gumma) with giant cells, and disruption of the tunica media (mesoaortitis). The sequela is the development of sacciform aneurysm of the ascending aorta and aortic arch, the rupture of which may precipitate sudden death (Figure 23a). Scarring with retraction of the tunica intima accounts for the specific pavement-like feature and superimposed atherosclerotic plaques (Figure 23b). An alternative theory for mesoaortitis is an obstructive disease of the vasa vasorum of the adventitia with plasma cell infiltrates (Figure 23c,d) causing ischemic damage to the lamellar units of the tunica media. This would explain the absence of syphilitic mesoaortitis in the abdominal aorta, where no vasa vasorum do exist. The mesoaortitis may involve also the sinus portion of the ascending aorta, with valve incompetence, coronary ostia stenosis and angina pectoris.
Infective endocarditis of the aortic valve may involve the annulus, accounting for abscesses and aneurysms in the Valsalva sinus. Optimal repair requires replacement of both valves and the ascending aorta using a homograft [41,42].
Mycotic aneurysm is another infectious disease of the aorta. The adjective refers to the look of the aneurysm, similar to a mushroom (or to a nuclear bomb). It develops as the consequence of microorganisms settling in the tunica media, usually cocci bacteriemia via the vasa vasorum, with a neutrophil inflammatory reaction, abscess and transmural necrosis, wall weakening, pseudo-aneurysm and external rupture (Figure 24). Atherosclerotic ulcers are an ideal nidus for bacteria implantation, directly from the aortic blood.
Giant cell angiitis involves non-infectious inflammation of the systemic arteries, with giant cell infiltrates in the absence of epithelioid granuloma. It usually affects the temporal artery in adult-elderly people (Horton arteritis). The involvement of the thoracic aorta, whether isolated or in association with the temporal artery, can be complicated with an aneurysm when the tunica media is extensively affected [43] (Figure 25). The diagnosis may come as a surprise at the time of surgical pathology examination since, clinically, it had been considered atherosclerotic.
Takayasu angiitis is a necrotizing arteritis typically involving the ascending aorta, the aortic arch and brachiocephalic arteries, with non-granuloma giant cells inflammation and elastic fiber disruption [44]. It affects mostly the young and is associated with intimal proliferation of brachiocephalic arteries and coronary stems (Figure 26) as well as fibrotic thickness of the adventitia, hindering aneurysm formation.
IgG4 aortitis-periaortitis occurs in 8% of IgG4-related systemic arteritis [45]. It involves more frequently the abdominal rather than thoracic aorta and is characterized by wall thickening and inflammatory infiltrates, consisting of IgGM-positive plasma cells and lymphocytes (Figure 27). When the ascending aorta is involved, coronary ostia may become stenotic as to require stenting.
Ankylosing spondylitis frequently affects the aorta, both thoracic and abdominal, in the form of aortitis [46,47,48,49].
Rheumatoid aortitis [48,50], Reiter’s Syndrome [51], Beçhet’s Disease [52,53,54] and Wegener’s granulomatosis [55,56] represent other systemic morbid entities with inflammatory involvement of the aorta.

3.5. Neoplasms

Malignant neoplasms of the aorta may be primary or secondary [57].
As far as primary sarcoma, they arise from the intima and appear at clinical imaging as a focal mass protruding into the aortic lumen, mimicking atherothrombosis (Figure 28).
As far as secondary malignancies, carcinoma of the esophagus (close to the aorta) may infiltrate and penetrate the aortic wall up to the aortic lumen (Figure 29). Massive gastrointestinal hemorrhage may occur, with blood leaking from the mouth like a fountain.

3.6. Thoracic Trauma

Penetrating or blunt trauma of the thorax may lead to aortic rupture, usually located in the region of the aortic arch, where the aorta is fixed to the pulmonary artery by the arterial ligament [58]. Traumatic torsion with stretching creates a transmural tear accounting for pseudoaneurysm and external rupture. (Figure 30). An overt aortic dissection is rare.
In conclusion, the aorta is like an organ, with smooth muscle cells of lamellar units as the “parenchyma”. Several diseases may affect the thoracic aorta: congenital, genetically determined, degenerative, inflammatory (both infectious and immune), neoplastic and traumatic. In several morbid entities, the aortic valve, ascending aorta and aortic arch represent an anatomo-pathological unit. Surgical replacement, of both the native aortic valve and ascending aorta, with an aortic homograft is an attractive therapeutic option (see below).

4. Aorta as Homograft

Aortic homograft from a cadaver, including both tubular and sinus portions with valves, is surgically employed to replace the native ascending aorta and aortic valve in several of the above-mentioned morbid conditions [59]. However, the ideal graft has not been accomplished so far; the antigenicity of the wall and valve cells triggers an immune cellular reaction.
Tissue engineering techniques can provide a valid approach to solve the problem.
So far, the main common techniques to realize bioengineered grafts are (1) in vitro cell seeding on biodegradable synthetic scaffolds, (2) in vitro cell seeding of decellularized natural scaffolds and (3) in vivo repopulation of decellularized natural scaffolds by circulating endogenous cells [60]. The last choice, however, can be the best to investigate cell repopulation and interaction with the extracellular matrix (ECM), which seems to play a pivotal role in tissue maintenance and regeneration, and modulates cell adhesion and migration, growth factor storage and release, stem cell activation and differentiation [61]. The decellularized homograft appears to be the best scaffold to realize the ideal graft with in vivo self-repopulation [62,63] because it can preserve regeneration capabilities, while the recipient child grows up.
Decellularization of natural scaffold-like aorta (or pulmonary) allografts represents the first step to remove immunogenic cells from both valve and lamellar units [64,65,66].
With this purpose, we carried out an investigation based on the hypothesis that decellularized homograft may serve as a scaffold for endogenous self-repopulation, thus preventing immune reaction and dystrophic calcification, which is a nightmare with current homografts. The research was carried out in healthy juvenile sheep (35–45 kg) by achieving complete decellularization in unimplanted aortic homograft through 0.5% sodium deoxycholate and 0.5% sodium dodecylsulphate and then implanted in allograft recipients, with a follow up of 14–18.5 months. The morphological study was performed in both aortic cusps and wall, with gross, X-ray, histology, immunohistochemistry, transmission electron microscopy and spectroscopy examinations. Results in detail have been reported elsewhere [67]. In summary:
  • Decellularization in unimplanted allografts appeared complete, both in the lamellar units of the tunica media and valvular interstitium with disappearance of endothelial lining (Figure 31);
  • Cellular repopulation was observed in the outer part of implanted homograft wall by novel smooth muscle cells in the lamellar units (Figure 32a,b) and in the intima with a novel myointimal layer; this layer was noticed also in small animals such as rodents [68]. Novel endothelial cells appeared to line both the aortic wall intima and inflow/outflow at the cusp surface, as well as vasa vasorum, and valve spongiosa appeared repopulated by interstitial cells (Figure 32c,d);
  • The ultrastructure of the wall revealed that novel smooth muscle cells have immature aspects, with a central oval nucleus, few contractile filaments and focal densities mainly located close to cytoplasmic membrane and in the paranuclear region; repopulated cells of the cusps are scarcely differentiated cells, in some case showing short intercellular junctions, rough endoplasmic reticulum and focal basal lamina (Figure 33), whereas others exhibited a fibroblast-like morphology;
  • The undifferentiated nature of the repopulated cells is demonstrated by colocalization of some biomarkers. Novel wall cells showed positivity both for α-SMA and vimentin and novel cusp cells for SMA, vWF, VEGF, VEGF R2, α-SMA and CD57 (HNK-1), which is a neural crest marker;
  • The origin of repopulated cells may be vasa vasorum for the homograft outer wall and the blood stream itself for cusps. Recently it has been demonstrated in a GFP rodent model that all novel cells belong to the recipient [68]. Bone marrow may be a source of progenitor cells (endothelial and mesenchymal cells) contributing to recruitment of smooth muscle-like cells [69,70]. Circulating bone-marrow-derived endogenous cells can be recruited in vivo by adhering to the intimal surface [71,72] and then recruited, undergoing an endothelial-to-mesenchymal transition (EMT) within the valve, followed by differentiation into interstitial cells that ultimately synthesize and remodel the ECM;
  • Cell density, when compared to non-decellularized control allografts, showed 20% repopulation both in the aortic wall and at the cusp level (Figure 34);
  • Mean calcium content by spectroscopy in aortic homografts at 14 months from implant was scanty: 4.24 ± 2.17 mg/g dry weight in the wall vs. 0.530 in controls and 5505 ± 2.04 in the cusps vs. 0.936 in the controls.
In conclusion, cell endogenous repopulation of decellularized homografts occurs at both aortic wall and cusps and persists after implantation, thus providing biological compatibility. An immune inflammatory reaction was not observed. The aortic cusps and wall showed no structural deterioration with negligible mineralization. Decellularized homograft may serve as ideal scaffold for self-repopulation from the recipient, transforming homograft into autograft, even if changes in the ECM constitution were found as compared to native tissue, which could lead to problems in cell growth and migration [63].
These results, however, represent a significant advancement when compared with cryopreserved homografts, which retain allografts cells as a target for immune inflammatory rejection and early calcification.
Finally, investigation of other more specific immunoreactive precursor cell markers is mandatory to study the repopulation cell phenotype and their proliferation modality, especially for the poorly differentiated elements found in the cusps.

Funding

This study was supported by the Registry for Cardio-cerebro-vascular Pathology, Veneto Region, Italy.

Acknowledgments

We thank the technical staff of Cardiovascular Pathology Unit of the University of Padua for the excellent collaboration.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Isselbacher, E.; Eagle, K.; Desanctis, R. Disease of the aorta. In Heart Disease: A Textbook of Cardiovascular Medicine; Braunwald, E., Ed.; W.B. Saunders Co.: Philadelphia, PA, USA, 1997; pp. 1546–1581. [Google Scholar]
  2. Buja, L.M.; Butany, J. Cardiovascular Pathology, 4th ed.; Academic Press; Elsevier: London, UK, 2016; ISBN 978-0-12-420219-1. [Google Scholar]
  3. Wolinsky, H.; Glagov, S. A Lamellar Unit of Aortic Medial Structure and Function in Mammals. Circ. Res. 1967, 20, 99–111. [Google Scholar] [CrossRef] [Green Version]
  4. El-Hamamsy, I.; Yacoub, M.H. Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat. Rev. Cardiol. 2009, 6, 771–786. [Google Scholar] [CrossRef] [PubMed]
  5. Majesky, M.W. Developmental Basis of Vascular Smooth Muscle Diversity. Arter. Thromb. Vasc. Biol. 2007, 27, 1248–1258. [Google Scholar] [CrossRef] [Green Version]
  6. Thiene, G.; Corrado, D.; Basso, C. Sudden Cardiac Death in the Young and Athletes: Text Atlas of Pathology and Clinical Correlates; Springer: Milan, Italy, 2016. [Google Scholar]
  7. Basso, C.; Boschello, M.; Perrone, C.; Mecenero, A.; Cera, A.; Bicego, D.; Thiene, G.; De Dominicis, E. An echocardiographic survey of primary school children for bicuspid aortic valve. Am. J. Cardiol. 2004, 93, 661–663. [Google Scholar] [CrossRef] [PubMed]
  8. Nistri, S.; Basso, C.; Marzari, C.; Mormino, P.; Thiene, G. Frequency of bicuspid aortic valve in young male conscripts by echo-cardiogram. Am. J. Cardiol. 2005, 96, 718–721. [Google Scholar] [CrossRef] [PubMed]
  9. Fernandes, S.M.; Khairy, P.; Sanders, S.; Colan, S.D. Bicuspid Aortic Valve Morphology and Interventions in the Young. J. Am. Coll. Cardiol. 2007, 49, 2211–2214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Sabet, H.Y.; Edwards, W.D.; Tazelaar, H.D.; Daly, R.C. Congenitally Bicuspid Aortic Valves: A Surgical Pathology Study of 542 Cases (1991 through 1996) and a Literature Review of 2715 Additional Cases. In Mayo Clinic Proceedings; Elsevier BV: Amsterdam, The Netherlands, 1999; Volume 74, pp. 14–26. [Google Scholar]
  11. McKusick, V.A. Association of congenital bicuspid aortic valve and Erdheim’s cystic medial necrosis. Lancet 1972, 1, 1026–1027. [Google Scholar] [CrossRef]
  12. Roberts, C.S.; Roberts, W.C. Dissection of the aorta associated with congenital malformation of the aortic valve. J. Am. Coll. Cardiol. 1991, 17, 712–716. [Google Scholar] [CrossRef] [Green Version]
  13. Verma, S.; Siu, S.C. Aortic Dilatation in Patients with Bicuspid Aortic Valve. New Engl. J. Med. 2014, 370, 1920–1929. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. El-Hamamsy, I.; Yacoub, M.H. A measured approach to managing the aortic root in patients with bicuspid aortic valve dis-ease. Curr. Cardiol. Rep. 2009, 11, 94–100. [Google Scholar] [CrossRef]
  15. Nistri, S.; Grande-Allen, J.; Noale, M.; Basso, C.; Siviero, P.; Maggi, S.; Crepaldi, G.; Thiene, G. Aortic elasticity and size in bicuspid aortic valve syndrome. Eur. Heart J. 2007, 29, 472–479. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Kappetein, A.P.; Gittenberger-de Groot, A.C.; Zwinderman, A.H.; Rohmer, J.; Poelmann, R.E.; Huysmans, H.A. The neural crest as a possible pathogenetic factor in coarctation of the aorta and bicuspid aortic valve. J. Thorac. Cardiovasc. Surg. 1991, 102, 830–836. [Google Scholar] [CrossRef]
  17. Sakakibara, S.; Konno, S. Congenital aneurysm of the sinus of Valsalva Anatomy and classification. Am. Heart J. 1962, 63, 405–424. [Google Scholar] [CrossRef]
  18. Morris, C.A.; Loker, J.; Ensing, G.; Stock, A.D. Supravalvular aortic stenosis cosegregates with a familial 6;7 translocation which disrupts the elastin gene. Am. J. Med. Genet. 1993, 46, 737–744. [Google Scholar] [CrossRef] [PubMed]
  19. Williams, J.C.P.; Barratt-Boyes, B.G.; Lowe, J.B. Supravalvular Aortic Stenosis. Circulation 1961, 24, 1311–1318. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Dietz, H.C.; Cutting, C.R.; Pyeritz, R.E.; Maslen, C.L.; Sakai, L.Y.; Corson, G.M.; Puffenberger, E.; Hamosh, A.; Nanthakumar, E.J.; Curristin, S.M.; et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nat. Cell Biol. 1991, 352, 337–339. [Google Scholar] [CrossRef] [PubMed]
  21. Loeys, B.L.; Schwarze, U.; Holm, T.; Callewaert, B.L.; Thomas, G.H.; Pannu, H.; De Backer, J.F.; Oswald, G.L.; Symoens, S.; Manouvrier, S.; et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N. Engl. J. Med. 2006, 355, 788–798. [Google Scholar] [CrossRef]
  22. Neptune, E.R.; Frischmeyer, P.A.; Arking, D.E.; Myers, L.; Bunton, T.E.; Gayraud, B.; Ramirez, F.; Sakai, L.Y.; Dietz, H.C. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 2003, 33, 407–411. [Google Scholar] [CrossRef] [PubMed]
  23. De Paepe, A.; Malfait, F. The Ehlers-Danlos syndrome.; a disorder with many faces. Clin. Genet. 2012, 82, 1–11. [Google Scholar] [CrossRef] [PubMed]
  24. Wenstrup, R.J.; A Meyer, R.; Lyle, J.S.; Hoechstetter, L.; Rose, P.S.; Levy, H.P.; A Francomano, C. Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. Genet. Med. 2002, 4, 112–117. [Google Scholar] [CrossRef] [Green Version]
  25. Turtle, E.J.; A Sule, A.; Webb, D.J.; E Bath, L. Aortic dissection in children and adolescents with Turner syndrome: Risk factors and management recommendations. Arch. Dis. Child. 2015, 100, 662–666. [Google Scholar] [CrossRef] [PubMed]
  26. Thompson, R.W.; Parks, W.C. Role of Matrix Metalloproteinases in Abdominal Aortic Aneurysms. Ann. N. Y. Acad. Sci. 1996, 800, 157–174. [Google Scholar] [CrossRef] [PubMed]
  27. Cooley, D.A. Annuloaortic Ectasia. Ann. Thorac. Surg. 1979, 28, 303–304. [Google Scholar] [CrossRef]
  28. Ellis, P.R.; Cooley, D.A.; De Bakey, M.E. Clinical considerations and surgical treatment of annulo-aortic ectasia. J. Thorac. Cardiovasc. Surg. 1961, 42, 363–370. [Google Scholar] [CrossRef]
  29. Beller, C.J.; Labrosse, M.; Thubrikar, M.J.; Robicsek, F. Role of Aortic Root Motion in the Pathogenesis of Aortic Dissection. Circulation 2004, 109, 763–769. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Evangelista, A.; Mukherjee, D.; Mehta, R.H.; O’Gara, P.T.; Fattori, R.; Cooper, J.V.; Smith, D.E.; Oh, J.K.; Hutchison, S.; Sechtem, U.; et al. International Registry of Aortic Dissection (IRAD) Investigators. Acute in-tramural hematoma of the aorta: A mystery in evolution. Circulation 2005, 111, 1063–1070. [Google Scholar] [CrossRef] [Green Version]
  31. Larson, E.W.; Edwards, W.D. Risk factors for aortic dissection: A necropsy study of 161 cases. Am. J. Cardiol. 1984, 53, 849–855. [Google Scholar] [CrossRef]
  32. Goldfinger, J.Z.; Halperin, J.L.; Marin, M.L.; Stewart, A.S.; Eagle, K.A.; Fuster, V. Thoracic Aortic Aneurysm and Dissection. J. Am. Coll. Cardiol. 2014, 64, 1725–1739. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Jondeau, G.; Boileau, C. Familial thoracic aortic aneurysms. Curr. Opin. Cardiol. 2014, 29, 492–498. [Google Scholar] [CrossRef] [PubMed]
  34. Ladich, E.; Butany, J.; Virmani, R. 5-Aneurysms of the Aorta: Ascending, Thoracic and Abdominal and Their Management. In Cardiovascular Pathology, 4th ed.; Buja, L.M., Butany, J., Eds.; Academic Press: Cambridge, MA, USA, 2016; pp. 169–211. ISBN 9780124202191. [Google Scholar]
  35. Pyeritz, R.E. Heritable thoracic aortic disorders. Curr. Opin. Cardiol. 2014, 29, 97–102. [Google Scholar] [CrossRef] [PubMed]
  36. Vaideeswar, P.; Dixit, V.; Butany, J.; David, T.E.; Feindel, C. Surgical pathology of chronic ascending aortic dissections. Pathology 2008, 40, 505–512. [Google Scholar] [CrossRef]
  37. Gornik, H.L.; Creager, M.A. Aortitis. Circulation 2008, 117, 3039–3051. [Google Scholar] [CrossRef]
  38. Virmani, R.; Burke, A.P. Pathologic features of aortitis. Cardiovasc. Pathol. 1994, 3, 205–216. [Google Scholar] [CrossRef]
  39. Virmani, R.; McAllister, H. Pathology of the aorta and major arteries. In Aortitis: Clinical, Pathologic, and Radiographic Aspects; Lande, A., Borkman, Y., McAllister, H., Eds.; Raven Press: New York, NY, USA, 1986; pp. 7–53. [Google Scholar]
  40. Heggtveit, H.A. Syphilitic aortitis. A clinicopathologic autopsy study of 100 cases, 1950 to 1960. Circulation 1964, 29, 346–355. [Google Scholar] [CrossRef] [Green Version]
  41. Musci, M.; Weng, Y.; Hübler, M.; Amiri, A.; Pasic, M.; Kosky, S.; Stein, J.; Siniawski, H.; Hetzer, R. Homograft aortic root replacement in native or prosthetic active infective endocarditis: Twenty-year single-center experience. J. Thorac. Cardiovasc. Surg. 2010, 139, 665–673. [Google Scholar] [CrossRef] [Green Version]
  42. Yanagawa, B.; Mazine, A.; Tam, D.Y.; Jüni, P.; Bhatt, D.L.; Spindel, S.; Puskas, J.D.; Verma, S.; Friedrich, J.O. Homograft Versus Conven-tional Prosthesis for Surgical Management of Aortic Valve Infective Endocarditis: A Systematic Review and Meta-analysis. Innovations 2018, 13, 163–170. [Google Scholar] [CrossRef]
  43. Evans, J.M.; Bowles, C.A.; Bjornsson, J.; Mullany, C.J.; Hunder, G.G. Thoracic aortic aneurysm and rupture in giant cell arteritis. a descriptive study of 41 cases. Arthritis Rheum. 1994, 37, 1539–1547. [Google Scholar] [CrossRef]
  44. Lupi-Herrera, E.; Sánchez-Torres, G.; Marcushamer, J.; Mispireta, J.; Horwitz, S.; Vela, J.E. Takayasu’s arteritis. Clinical study of 107 cases. Am. Heart. J. 1977, 93, 94–103. [Google Scholar] [CrossRef]
  45. Stone, J.H.; Khosroshahi, A.; Deshpande, V.; Stone, J.R. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Rheum. 2010, 62, 316–322. [Google Scholar] [CrossRef]
  46. Ansell, B.M.; Bywaters, E.G.L.; Doniach, I. The aortic lesion of ankylosing spondylitis. Br. Heart J. 1958, 20, 507–515. [Google Scholar] [CrossRef] [Green Version]
  47. Bulkley, B.H.; Roberts, W.C. Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation 1973, 48, 1014–1027. [Google Scholar] [CrossRef] [Green Version]
  48. Arnason, J.A.; Patel, A.K.; Rahko, P.S.; Sundstrom, W.R. Transthoracic and transesophageal echocardiographic evaluation of the aortic root and subvalvular structures in ankylosing spondylitis. J. Rheumatol. 1996, 23, 120–123. [Google Scholar] [PubMed]
  49. Palazzi, C.; D’ Angelo, S.; Lubrano, E.; Olivieri, I. Aortic involvement in ankylosing spondylitis. Clin. Exp. Rheumatol. 2008, 26 (Suppl. 49), S131–S134. [Google Scholar]
  50. Reimer, K.A.; Rodgers, R.F.; Oyasu, R. Rheumatoid Arthritis With Rheumatoid Heart Disease and Granulomatous Aortitis. JAMA 1976, 235, 2510–2512. [Google Scholar] [CrossRef]
  51. Paulus, H.E.; Pearson, C.M.; Pitts, W., Jr. Aortic insufficiency in five patients with Reiter’s syndrome. A detailed clinical and pathologic study. Am. J. Med. 1972, 53, 464–472. [Google Scholar] [CrossRef]
  52. Chajek, T.; Fainaru, M. Behcet’s disease. Report of 41 cases and a review of the literature. Medicine 1975, 54, 179–196. [Google Scholar] [CrossRef]
  53. Hamza, M. Large artery involvement in Behcet’s disease. J. Rheumatol. 1987, 14, 554–559. [Google Scholar]
  54. Tuzun, H.; Besirli, K.; Sayin, A.; Vural, F.S.; Hamuryudan, V.; Hizli, N.; Yurdakul, S.; Yazici, H. Management of aneurysms in Behcet’s syndrome: An analysis of 24 patients. Surgery 1997, 121, 150–156. [Google Scholar] [CrossRef]
  55. Blockmans, D.; Baeyens, H.; Van Loon, R.; Lauwers, G.; Bobbaers, H. Periaortitis and aortic dissection due to Wegener’s granu-lomatosis. Clin. Rheumatol. 2000, 19, 161–164. [Google Scholar] [CrossRef]
  56. Unlü, C.; Willems, M.; Ten Berge, I.J.; Legemate, D.A. Aortitis with aneurysm formation as a rare complication of Wegener’s granulomatosis. J. Vasc. Surg. 2011, 54, 1485–1487. [Google Scholar] [CrossRef]
  57. Chiche, L.; Mongrédien, B.; Brocheriou, I.; Kieffer, E. Primary Tumors of the Thoracoabdominal Aorta: Surgical Treatment of 5 Patients and Review of the Literature. Ann. Vasc. Surg. 2003, 17, 354–364. [Google Scholar] [CrossRef]
  58. Neschis, D.G.; Scalea, T.M.; Flinn, W.R.; Griffith, B.P. Blunt Aortic Injury. N. Eng. J. Med. 2008, 359, 1708–1716. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Eugene, H.B.; Frank, L.H.; James, K.K.; Nicholas, T. Kouchoukos Kirklin/Barratt-Boyes. Cardiac Surgery; Expert Consult. Saunders: Milan, Italy, 2012; ISBN 9781416063919. [Google Scholar]
  60. Mendelson, K.; Schoen, F.J. Heart valve tissue engineering: Concepts, approaches, progress, and challenges. Ann. Biomed. Eng. 2006, 34, 1799–1819. [Google Scholar] [CrossRef] [Green Version]
  61. Flaumenhaft, R.; Moscatelli, D.; Saksela, O.; Rifkin, D.B. Role of extracellular matrix in the action of basic fibroblast growth factor: Ma-trix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J. Cell. Physiol. 1989, 140, 75–81. [Google Scholar] [CrossRef] [PubMed]
  62. Baraki, H.; Tudorache, I.; Braun, M.; Höffler, K.; Görler, A.; Lichtenberg, A.; Bara, C.; Calistru, A.; Brandes, G.; Hewicker-Trautwein, M.; et al. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials 2009, 30, 6240–6246. [Google Scholar] [CrossRef]
  63. Grauss, R.W.; Hazekamp, M.G.; Oppenhuizen, F.; Van Munsterena, C.J.; Groot, A.C.G.-D.; DeRuiter, M.C. Histological evaluation of decellularised porcine aortic valves: Matrix changes due to different decellularisation methods. Eur. J. Cardio-Thorac. Surg. 2005, 27, 566–571. [Google Scholar] [CrossRef]
  64. Cebotari, S.; Lichtenberg, A.; Tudorache, I.; Hilfiker, A.; Mertsching, H.; Leyh, R.; Breymann, T.; Kallenbach, K.; Maniuc, L.; Batrinac, A.; et al. Clinical application of tissue engineered human heart valves using autolo-gous progenitor cells. Circulation 2006, 114, I132–I137. [Google Scholar] [CrossRef] [Green Version]
  65. Cebotari, S.; Tudorache, I.; Jaekel, T.; Hilfiker, A.; Dorfman, S.; Ternes, W.; Haverich, A.; Lichtenberg, A. Detergent Decellularization of Heart Valves for Tissue Engineering: Toxicological Effects of Residual Detergents on Human Endothelial Cells. Artif. Organs 2010, 34, 206–210. [Google Scholar] [CrossRef]
  66. Tudorache, I.; Theodoridis, K.; Samir, S.; Bara, C.; Meyer, T.; Höffler, K.; Hartung, D.; Hilfiker, A.; Haverich, A.; Cebotari, S. Decellular-ized aortic allograft vs pulmonary autograft for aortic valve replacement in growing sheep model: Haemodynamic and morphological results after implantation for 20 months. Circulation 2014, 130, A20027. [Google Scholar]
  67. Della Barbera, M.; Valente, M.; Basso, C.; Thiene, G. Morphologic studies of cell endogenous repopulation in decellularized aortic and pulmonary homografts implanted in sheep. Cardiovasc Pathol. 2015, 24, 102–109. [Google Scholar] [CrossRef]
  68. Dedja, A.; Padalino, M.A.; Della Barbera, M.; Rasola, C.; Pesce, P.; Milan, A.; Pozzobon, M.; Sacerdoti, D.; Thiene, G.; Stellin, G. Heterotopic Implantation of Decellularized Pulmonary Artery Homografts In A Rodent Model: Technique Description and Preliminary Report. J. Investig. Surg. 2017, 31, 282–291. [Google Scholar] [CrossRef]
  69. Sata, M.; Fukuda, D.; Tanaka, K.; Kaneda, Y.; Yashiro, H.; Shirakawa, I. The role of circulating precursors in vascular repair and lesion formation. J. Cell. Mol. Med. 2005, 9, 557–568. [Google Scholar] [CrossRef]
  70. Frid, M.G.; Kale, V.A.; Stenmark, K.R. Mature vascular endothelium can give rise to smooth muscle cells via endotheli-al-mesenchymal transdifferentiation: In vitro analysis. Circ. Res. 2002, 90, 1189–1196. [Google Scholar] [CrossRef] [Green Version]
  71. Deb, A.; Wang, S.H.; Skelding, K.; Miller, D.; Simper, D.; Caplice, N. Bone marrow-derived myofibroblasts are present in adult human heart valves. J. Heart Valve Dis. 2005, 14, 674–678. [Google Scholar]
  72. Armstrong, E.J.; Bischoff, J. Heart valve development: Endothelial cell signaling and differentiation. Circ. Res. 2004, 95, 459–470. [Google Scholar] [CrossRef] [Green Version]
Figure 1. (a) Normal thoracic aorta in a child; (b) Severe atherosclerosis of the aorta in an old man.
Figure 1. (a) Normal thoracic aorta in a child; (b) Severe atherosclerosis of the aorta in an old man.
Jcdd 08 00076 g001
Figure 2. Histology of thoracic aorta. (a) The media consists of lamellar units with parallel elastic fibers. Weigert Van Gieson stain. (b) Smooth muscle cells, dark stained by anti-SMC immunohistochemistry, are the “parenchyma”. (c) The lamellar unit consists of elastic fibers, with vascular smooth muscle cells (VSMCs) and extracellular matrix (ECM) in between. Adapted from [4].
Figure 2. Histology of thoracic aorta. (a) The media consists of lamellar units with parallel elastic fibers. Weigert Van Gieson stain. (b) Smooth muscle cells, dark stained by anti-SMC immunohistochemistry, are the “parenchyma”. (c) The lamellar unit consists of elastic fibers, with vascular smooth muscle cells (VSMCs) and extracellular matrix (ECM) in between. Adapted from [4].
Jcdd 08 00076 g002
Figure 3. Prevalence of BAV in children (a) and conscript soldiers (b,c) by echo. Adapted from [7,8], with permission.
Figure 3. Prevalence of BAV in children (a) and conscript soldiers (b,c) by echo. Adapted from [7,8], with permission.
Jcdd 08 00076 g003
Figure 4. Bicuspid aortic valve, type 1 and 2. Note the raphe without the interleaflet triangle underneath.
Figure 4. Bicuspid aortic valve, type 1 and 2. Note the raphe without the interleaflet triangle underneath.
Jcdd 08 00076 g004
Figure 5. Aortopathy in the bicuspid valve. Note normal (a) vs. dilated (b) ascending aorta with loss of lamellar units at histology (c). (Weigert Van Gieson stain).
Figure 5. Aortopathy in the bicuspid valve. Note normal (a) vs. dilated (b) ascending aorta with loss of lamellar units at histology (c). (Weigert Van Gieson stain).
Jcdd 08 00076 g005
Figure 6. (a) Dissection of dilated ascending aorta in the bicuspid aortic valve, with intimal tear just above the commissures. (b,c) On histology, wave front propagation of the dissecting hematoma and medial necrosis. (Weigert Van Gieson stain).
Figure 6. (a) Dissection of dilated ascending aorta in the bicuspid aortic valve, with intimal tear just above the commissures. (b,c) On histology, wave front propagation of the dissecting hematoma and medial necrosis. (Weigert Van Gieson stain).
Jcdd 08 00076 g006
Figure 7. Infective endocarditis (a) with cocci (b) in a young drug addict with bicuspid aortic valve. (Gram stain).
Figure 7. Infective endocarditis (a) with cocci (b) in a young drug addict with bicuspid aortic valve. (Gram stain).
Jcdd 08 00076 g007
Figure 8. Isthmic aortic coarctation. (a) Plication at the aortic arch. (b) Corresponding histology. (Weigert Van Gieson stain).
Figure 8. Isthmic aortic coarctation. (a) Plication at the aortic arch. (b) Corresponding histology. (Weigert Van Gieson stain).
Jcdd 08 00076 g008
Figure 9. Long-axis (a) and hour-glass appearance (b) of supravalvular aortic stenosis in William’s syndrome.
Figure 9. Long-axis (a) and hour-glass appearance (b) of supravalvular aortic stenosis in William’s syndrome.
Jcdd 08 00076 g009
Figure 10. Aortic dissection in Marfan syndrome and sudden death. (a) Gross view: intimal tear in the tubular ascending aorta and mitral valve prolapse. (b) Histology of the aortic wall: severe elastic fibers frequent in aortic dissection. (Weigert Van Gieson stain).
Figure 10. Aortic dissection in Marfan syndrome and sudden death. (a) Gross view: intimal tear in the tubular ascending aorta and mitral valve prolapse. (b) Histology of the aortic wall: severe elastic fibers frequent in aortic dissection. (Weigert Van Gieson stain).
Jcdd 08 00076 g010
Figure 11. The aorta in Loeys-Dietz syndrome. Notice the large anuloaortic ectasia (a,b) by tomography. From Rizzo S et al. Ann Thorac Surg. 2016 Mar; 101(3):1193-5, with permission.
Figure 11. The aorta in Loeys-Dietz syndrome. Notice the large anuloaortic ectasia (a,b) by tomography. From Rizzo S et al. Ann Thorac Surg. 2016 Mar; 101(3):1193-5, with permission.
Jcdd 08 00076 g011
Figure 12. (a) Atherothrombosis of the thoracic aorta, gross view. (b,c) Histology of atherosclerotic plaque. (Weigert Van Gieson and C-68 immuno stains).
Figure 12. (a) Atherothrombosis of the thoracic aorta, gross view. (b,c) Histology of atherosclerotic plaque. (Weigert Van Gieson and C-68 immuno stains).
Jcdd 08 00076 g012
Figure 13. Ulcer of atherosclerotic plaque with intramural hematoma, false aneurysm and external rupture.
Figure 13. Ulcer of atherosclerotic plaque with intramural hematoma, false aneurysm and external rupture.
Jcdd 08 00076 g013
Figure 14. Atherosclerotic saccular aneurysm of the abdominal aorta. (a) Gross features. (b) Histology with atheroma disrupting the tunica media, with loss of elastic fibers and thinning. (Weigert Van Gieson stain).
Figure 14. Atherosclerotic saccular aneurysm of the abdominal aorta. (a) Gross features. (b) Histology with atheroma disrupting the tunica media, with loss of elastic fibers and thinning. (Weigert Van Gieson stain).
Jcdd 08 00076 g014
Figure 15. Elementary degenerative lesions in the tunica media of the aorta. (a) Non-inflammation loss (medionecrosis) of smooth muscle cells (SMCs). (b) Elastic fragmentation. (c) Cystic medial necrosis. (Hematoxylin-eosin (a), Weigert Van Gieson (b), and Alcian PAS (c) stains).
Figure 15. Elementary degenerative lesions in the tunica media of the aorta. (a) Non-inflammation loss (medionecrosis) of smooth muscle cells (SMCs). (b) Elastic fragmentation. (c) Cystic medial necrosis. (Hematoxylin-eosin (a), Weigert Van Gieson (b), and Alcian PAS (c) stains).
Jcdd 08 00076 g015
Figure 16. (a) Gross view of a dilated ascending aorta with aortic valve incompetence (anuloaortic-ectasia), due to degenerative disease of the aortic tunica media, not genetically determined. (b) Severe disruption of the elastic fibers in the tunica media. (Weigert Van Gieson stain).
Figure 16. (a) Gross view of a dilated ascending aorta with aortic valve incompetence (anuloaortic-ectasia), due to degenerative disease of the aortic tunica media, not genetically determined. (b) Severe disruption of the elastic fibers in the tunica media. (Weigert Van Gieson stain).
Jcdd 08 00076 g016
Figure 17. Angiographic (a) and intraoperative (b) gross views of non-inflammatory anuuloaortic ectasia with valve incompetence.
Figure 17. Angiographic (a) and intraoperative (b) gross views of non-inflammatory anuuloaortic ectasia with valve incompetence.
Jcdd 08 00076 g017
Figure 18. Aortic dissection with intimal tear (a) and dissection of the ascending aorta (b).
Figure 18. Aortic dissection with intimal tear (a) and dissection of the ascending aorta (b).
Jcdd 08 00076 g018
Figure 19. (a) Scanning electron microscopy views of an intimal tear in aortic dissection. (b) Stretch of the aorta during hypertension attack, accounting for intimal tear and aortic dissection. Adapted from [29], with permission.
Figure 19. (a) Scanning electron microscopy views of an intimal tear in aortic dissection. (b) Stretch of the aorta during hypertension attack, accounting for intimal tear and aortic dissection. Adapted from [29], with permission.
Jcdd 08 00076 g019
Figure 20. Intramural hematoma in the absence of intimal tear. (a) Schematic drawing. (b) Gross cross section of the aorta, with intramural hematoma. (c) Scattered elastic disruption. (Weigert Van Gieson stain). (a) Adapted from [30].
Figure 20. Intramural hematoma in the absence of intimal tear. (a) Schematic drawing. (b) Gross cross section of the aorta, with intramural hematoma. (c) Scattered elastic disruption. (Weigert Van Gieson stain). (a) Adapted from [30].
Jcdd 08 00076 g020
Figure 21. Double barrel aorta in chronic aortic dissection. (a) Gross view. (b) Corresponding histology. (Weigert Van Gieson stain).
Figure 21. Double barrel aorta in chronic aortic dissection. (a) Gross view. (b) Corresponding histology. (Weigert Van Gieson stain).
Jcdd 08 00076 g021
Figure 22. (ac) Drawing of aortic incompetence due to retrograde aortic dissection. (d,e) Retrograde dissection involves and occludes the left coronary artery main stem (Azan Mallory stain).
Figure 22. (ac) Drawing of aortic incompetence due to retrograde aortic dissection. (d,e) Retrograde dissection involves and occludes the left coronary artery main stem (Azan Mallory stain).
Jcdd 08 00076 g022
Figure 23. (a) Huge saccular syphilitic aneurysm of the aortic arch (from the Morgagni Museum of the Institute of Pathological Anatomy, University of Padua, with permission). (b) Syphilitic ascending aorta with pavement-like appearance of the intima. (c,d) Plasma cell inflammatory infiltrates in the obstructed vasa vasorum. (Hematoxylin-eosin and anti-CD79 immuno stain).
Figure 23. (a) Huge saccular syphilitic aneurysm of the aortic arch (from the Morgagni Museum of the Institute of Pathological Anatomy, University of Padua, with permission). (b) Syphilitic ascending aorta with pavement-like appearance of the intima. (c,d) Plasma cell inflammatory infiltrates in the obstructed vasa vasorum. (Hematoxylin-eosin and anti-CD79 immuno stain).
Jcdd 08 00076 g023
Figure 24. Mycotic aneurysm of the ascending aorta. (a) Gross appearance. (b) Histology: through and through laceration of the aortic wall with false aneurysm (Alcian PAS stain). (c) Same as (b) (Weigert Van Gieson stain). (d) Abscess by cocci in the aortic wall (hematoxylin-eosin stain).
Figure 24. Mycotic aneurysm of the ascending aorta. (a) Gross appearance. (b) Histology: through and through laceration of the aortic wall with false aneurysm (Alcian PAS stain). (c) Same as (b) (Weigert Van Gieson stain). (d) Abscess by cocci in the aortic wall (hematoxylin-eosin stain).
Jcdd 08 00076 g024
Figure 25. Giant cell aortitis with massive inflammatory disease: (a) panoramic view; (b) high-power view: note the giant cells (hematoxylin-eosin stain).
Figure 25. Giant cell aortitis with massive inflammatory disease: (a) panoramic view; (b) high-power view: note the giant cells (hematoxylin-eosin stain).
Jcdd 08 00076 g025
Figure 26. Takayasu arteritis in a 17-year-old girl. (a) Angiogram with typical obstruction of the brachiocephalic arteries. (b) Cross-section of the left carotid artery: note the severe stenosis of the lumen and the thickness of the adventitia (Weigert Van Gieson stains). (c) Giant cell inflammatory infiltrates (hematoxylin-eosin stain). (d) Necrotizing angiitis with disruption of the tunica media (close up of (b)). (e) Left coronary artery stem stenosis by selective coronary angiography with obstructed ostium. (f) Corresponding histology (Weigert Van Gieson stain).
Figure 26. Takayasu arteritis in a 17-year-old girl. (a) Angiogram with typical obstruction of the brachiocephalic arteries. (b) Cross-section of the left carotid artery: note the severe stenosis of the lumen and the thickness of the adventitia (Weigert Van Gieson stains). (c) Giant cell inflammatory infiltrates (hematoxylin-eosin stain). (d) Necrotizing angiitis with disruption of the tunica media (close up of (b)). (e) Left coronary artery stem stenosis by selective coronary angiography with obstructed ostium. (f) Corresponding histology (Weigert Van Gieson stain).
Jcdd 08 00076 g026
Figure 27. IgG4 aortitis. (a) Ascending aorta with increased thickness of the wall. (b) Histology: the thickness is located in the adventitia. Weigert Van Gieson stain. (cf) Inflammatory infiltrates consist mostly of plasma cells. (c) Hematoxylin-Eosin. (d) CD79a immunohistochemistry for plasma cells. (e) Immunohistochemistry for any IgG. (f) Immunohistochemistry for IgG4.
Figure 27. IgG4 aortitis. (a) Ascending aorta with increased thickness of the wall. (b) Histology: the thickness is located in the adventitia. Weigert Van Gieson stain. (cf) Inflammatory infiltrates consist mostly of plasma cells. (c) Hematoxylin-Eosin. (d) CD79a immunohistochemistry for plasma cells. (e) Immunohistochemistry for any IgG. (f) Immunohistochemistry for IgG4.
Jcdd 08 00076 g027
Figure 28. Intimal masses protruding into the lumen of the descending thoracic aorta at selective (a) and at tomography angiography (b). (c) Gross appearance of the specimens removed at surgery. (d) Malignant histiocytoma at histology (hematoxylin-eosin).
Figure 28. Intimal masses protruding into the lumen of the descending thoracic aorta at selective (a) and at tomography angiography (b). (c) Gross appearance of the specimens removed at surgery. (d) Malignant histiocytoma at histology (hematoxylin-eosin).
Jcdd 08 00076 g028
Figure 29. Carcinoma of the esophagus, infiltrating the adjacent aorta and penetrating in the aortic lumen, with massive hematemesis (a) Gross view. (b) Close up.
Figure 29. Carcinoma of the esophagus, infiltrating the adjacent aorta and penetrating in the aortic lumen, with massive hematemesis (a) Gross view. (b) Close up.
Jcdd 08 00076 g029
Figure 30. Fatal case of traumatic transmural aortic rupture at isthmic level by blunt trauma.
Figure 30. Fatal case of traumatic transmural aortic rupture at isthmic level by blunt trauma.
Jcdd 08 00076 g030
Figure 31. Decellularization of unimplanted aortic homograft: wall (a,b) and cusps (c,d). Elastic fibers and ground substance of extracellular matrix are preserved (hematoxylin-eosin, Heidenhein and Alcian PAS stain). From [67], with permission.
Figure 31. Decellularization of unimplanted aortic homograft: wall (a,b) and cusps (c,d). Elastic fibers and ground substance of extracellular matrix are preserved (hematoxylin-eosin, Heidenhein and Alcian PAS stain). From [67], with permission.
Jcdd 08 00076 g031
Figure 32. Repopulation by smooth muscle cells of the outer aortic wall (a,b) with neo endothelial lining (a) of a decellularized homograft, 14 months from implant (anti-α-SMA). (c,d) Repopulation after 14 months of implantation of decellularized homograft aortic cusps by smooth muscle cells and endothelial cells (anti-α-SMA and VWF). From [67], with permission.
Figure 32. Repopulation by smooth muscle cells of the outer aortic wall (a,b) with neo endothelial lining (a) of a decellularized homograft, 14 months from implant (anti-α-SMA). (c,d) Repopulation after 14 months of implantation of decellularized homograft aortic cusps by smooth muscle cells and endothelial cells (anti-α-SMA and VWF). From [67], with permission.
Jcdd 08 00076 g032
Figure 33. (a) Repopulating smooth muscle cells with basal lamina (arrows) and few contractile filaments with focal densities, close to the cytoplasmic membrane and in the paranuclear region (arrowheads). (b) Implanted pulmonary homograft cusps: poorly differentiated cells with intercellular junctions (arrows), rough endoplasmic reticulum, and focal basal lamina (arrowhead). From [67].
Figure 33. (a) Repopulating smooth muscle cells with basal lamina (arrows) and few contractile filaments with focal densities, close to the cytoplasmic membrane and in the paranuclear region (arrowheads). (b) Implanted pulmonary homograft cusps: poorly differentiated cells with intercellular junctions (arrows), rough endoplasmic reticulum, and focal basal lamina (arrowhead). From [67].
Jcdd 08 00076 g033
Figure 34. Histogram displaying cell density per millimeter squared in native vs. implanted decellularized conduit wall and cusps. A 20% repopulation occurred. All values are expressed as mean ± S.D. From [67].
Figure 34. Histogram displaying cell density per millimeter squared in native vs. implanted decellularized conduit wall and cusps. A 20% repopulation occurred. All values are expressed as mean ± S.D. From [67].
Jcdd 08 00076 g034
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Thiene, G.; Basso, C.; Della Barbera, M. Pathology of the Aorta and Aorta as Homograft. J. Cardiovasc. Dev. Dis. 2021, 8, 76. https://0-doi-org.brum.beds.ac.uk/10.3390/jcdd8070076

AMA Style

Thiene G, Basso C, Della Barbera M. Pathology of the Aorta and Aorta as Homograft. Journal of Cardiovascular Development and Disease. 2021; 8(7):76. https://0-doi-org.brum.beds.ac.uk/10.3390/jcdd8070076

Chicago/Turabian Style

Thiene, Gaetano, Cristina Basso, and Mila Della Barbera. 2021. "Pathology of the Aorta and Aorta as Homograft" Journal of Cardiovascular Development and Disease 8, no. 7: 76. https://0-doi-org.brum.beds.ac.uk/10.3390/jcdd8070076

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop